Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.

NCT: NCT07389824 · RECRUITING

NCT IDNCT07389824
StatusRECRUITING
Start Date2026-02-01
Completion2027-12-31
SponsorQin Yu (OTHER)
First posted
Last updated

Brief Summary

This study aims to evaluate the efficacy and safety of acupuncture combined with mesalazine (an integrated acupuncture-medication regimen) for ulcerative colitis.

Frequently Asked Questions

What is Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.?

Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis. is a clinical trial registered under NCT07389824. Current status: RECRUITING.

What is the status of NCT07389824?

The current status of NCT07389824 (Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.) is: RECRUITING.

When did Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis. start?

Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis. started on 2026-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑